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1. Introduction 
High molecular weight (HMW) kininogen found in 
mammalian blood plasma is one of the functional 
glycoproteins, which participates in the kallikrein- 
kinin system [l] . Quite recently, a new function of 
this protein has been suggested by findings of Flaujeac 
and Williams traits with a deficiency of the kininogen 
[2,3] . The deficient plasma does not release kinin 
upon incubation of kallikrein and also has a prolonged 
activated partial thromboplastin time and inability to 
form plasmin. These suggest a participation of the 
kininogen on the intrinsic blood coagulation and 
fibrinolysis, in addition to the kinin-forming system. 
In order to realize these physiological functions, 
it seems important to study the chemical structure of 
kininogen. Previously, we reported that a few of pep- 
tide fragments, in addition to kinin, were liberated 
from HMW kininogen on the digestion with plasma 
kallikrein [4]. One of the fragments was found to 
contain an abnormally high level of histidine (named 
tentatively histidine-rich peptide), and its amino acid 
sequence was established [5] . This communication 
describes further studies on the chemical composi- 
tions of kinin-free kininogen and peptide fragments 
produced from HMW kininogen by plasma kallikrein. 
* Present address: Research and Development Division, 
Dainippon Pharmaceutical Co., Ltd., Enoki-33-94, Suita, 
Osaka-564. 
Abbreviations: HMW kininogen, high molecular weight kinin- 
ogen; SDS, sodium dodecylsulfate; TAME, N-o-tosyl-L-argi- 
nine methylester. 
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2. Materials and methods 
Highly purified HMW kininogen was prepared from 
fresh bovine plasma by the previous method [6]. 
Bovine plasma kallikrein was prepared from highly 
purified prekallikrein [7] , by activating it with puri- 
fied bovine prekallikrein activator (Factor XIIa) [8]. 
The specific activity of the kallikrein was 23.5 TAME 
units per mg protein [7]. Sephadex G-25 (super tine), 
G-50 (fine) and G-100 were products of Pharmacia, 
Uppsala, Sweden. Kinin activity was assayed in terms 
of its ability to cause smooth muscle contraction of 
isolated rat uterus [9]. For the analysis of amino 
acids, peptides were hydrolyzed in 0.5 ml of constant- 
boiling HCl in evacuated, sealed tubes at 110°C for 
24,48 and 72 h. The sample was analyzed with an 
amino acid analyzer, Model JLC-SAH, Japan Electron 
Optics, Ltd., by the method of Spa&man et al. [IO]. 
The N-terminal residues of the isolated peptides and 
whole proteins were determined by Edman’s phenyl- 
isothiocyanate procedure [ 1 l] and Sanger’s method 
[ 121. For the analysis of carbohydrates, total hexoses 
were measured by the phenol-sulfuric acid method of 
Dubois et al. [13] , using a standard solution contain- 
ing equimolar amounts of D-galactose and D-mannose. 
The separation of glucosamine and galactosamine were 
made as described by Spiro [ 141, and hexosamines 
and sialic acid were estimated by the methods of 
Blix [ 151 and the periodate-thiobarbituric acid 
method of Warren [ 161 , respectively. 
3. Results 
HMW kininogen (80 mg) was incubated with 78 
North-Holland Publishing Company - Amsterdam 
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gg of plasma kallikrein (1.8 TAME units) in 5.0 ml 
of 0.2 M ammonium bicarbonate buffer, pH 8.0, at 
37’C. After incubation for 2 h, 0.1 M DFP was added 
to give a final concentration of 10m3 M, and the mix- 
ture was stood for 4 h. The mixture was then gkl-fil- 
trated through a column of Sephadex G-50 equilib- 
rated with 0.2 M ammonium bicarbonate buffer, pH 
8.0, and the effluent was analyzed by U.V. absorp- 
tion at 280 nm, ninhydrin reaction and smooth mus- 
cle contraction of isolated rat uterus. Through this 
procedure, three fragments showing U.V. absorption 
and one fragment with kinin activity were separated. 
The large fragment eluted in the void volume fraction 
was kinin-free kininogen, which showed no more 
release of the kinin upon incubation with kallikrein. 
The other two fragments, which were eluted in a low 
molecular weight fraction and separated from the 
kinin, were a glycopeptide (fragment 1) and histi- 
dine-rich peptide (fragment 2) [S] . 
The kinin-free kininogen was subsequently reduced 
and carboxymethylated [ 171 and the resulting S-alky- 
lated material was separated on a Sephadex G-100 
column equilibrated with the same buffer used before. 
The elution pattern is shown in Fig. 1, Two large frag- 
ments, named heavy (H) and light(L) chains, were 
resolved clearly, and these were gel-electrophoretic- 
ally pure, as shown in the inlet of the figure. 
Table 1 shows amino acid and carbohydrate com- 
positions of all the fragments thus isolated. The frag- 
ment 1 and fragment 2 contained extremely high 
levels of histidine and glycine, and their N-terminal 
residues were both serine. Moreover, the fragment 1 
was found to be glycopeptide containing a total of 
7.4% of carbohydrates. 
On the other hand, the amino acid compositions 
of H- and Lchains derived from kinin-free kininogen 
were different for each other. Especially, Lchain 
showed a characteristic composition, in which a sum 
of five amino acid residues, Asp, Thr, Ser, Glu and 
Pro, comprises 57% of the total residues. Another 
difference between the two was the presence of 
galactosamine in Lchain but not in H-chain. More- 
over, no clear N-terminal residue reactive to phenyl- 
isothiocyanate and 2,4-dinitrofluorobenzene was 
detected in H-chain as well as whole HMW kininogen 
[ 181, whereas the N-terminal threonine was identified 
evidently on L-chain. The C-terminal residue of L-chain 
was identified to be leucine, which was the same resi- 
due as that of whole HMW kininogen [ 181. 
FRACTION NUMBER ( 4 ml /tubr 1 
Fig.1. Separation of the heavy (H) and light (L) chains con- 
stituting kinin-free HMW kminogen on a Sephadex G-100 
column. The Salkylated sample (30 mg) dissolved in 1 ml 
of 0.2 M (NH,)HCO, buffer, pH 8.0, was applied to the 
column (2 cm X 94 cm) and eluted with the same buffer 
at a flow rate of 20 ml/h. SDS polyacrylamide-gel(8%) 
electrophoresis was done at room temperature at a current 
of 8 mA per tube for 4 h, according to the method of 
Weber and Osborn [ 2 1 ] . 
4. Discussion 
Bovine-HMW kininogen having a molecular weight 
of 76 000 consists of a single chain polypeptide with 
a masked N-terminal residue and C-terminakleucine, 
and it carries the vasoactive peptide, bradykinin, in 
the interior of the chain bridged by a disulfide bond 
[ 181. This kininogen liberates two peptide fragments, 
in addition to kinin, on the digestion with plasma 
kallikrein. One of the fragments, histidine-rich pep- 
tide, contains a total of 41 amino acid residues with 
the N-terminal serine and C-terminal arginine [5] . 
The other fragment is a glycopeptide containing also 
high level of histidine (Table l), and the partial N- 
terminal sequence of Ser-Val-Gln-Val-Met-Lys-Thr- 
Glu-Gly- is the same as the C-terminal sequence of 
the CNBr-fragment containing kallidin [18,19]. Thus, 
this glycopeptide fragment must be connected with 
the C-terminus of the kinin along the polypeptide 
chain of kininogen. 
The residual protein, named kinin-free kininogen, 
which consists of two chain polypeptides of H- and 
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Table 1 
Chemical composition of kinin-free kir.inogen and fragments derived from HMW kininogen with plasma kallikrein. 
Amino acid compositions of each fragment were corrected values from the hydrolysates for 24,48 and 72 h at 110°C except fragment 1. The values of 
fragment 1 were from the hydrolysate for 24 h at 110°C and those of fragment 2 were from the complete amino acid sequence determined previously [S] 
Amino acid 
Kinin-free 
kininogen 
+ 
HMW Kinin-free fragment l- 
kininoga?) kininogen H-chain L-chain H+L fragment 1 fragment 2 BK + 
fragment 2 
+ 
BK 
ASP 63 60 
Thr 41 40 
Ser 49 44 
clu 64 51 
PI0 39 35 
GY 39 20 
Ala 31 31 
l/ZCys 20 18 
Val 38 35 
Met 8 6 
ne 22 22 
Leu 36 33 
TYr 19 17 
Phe 20 20 
Trp 8 6 
His 28 12 
LYS 43 35 
kg 13 11 
- residues per mole - 
45 15 60 4 4 68 
26 14 40 4 44 
32 13 45 6 1 1 52 
44 14 58 9 2 68 
21 13 34 3 3 41 
17 3 20 11 11 1 43 
23 1 30 1 - 32 
17 1 18 - 18 
28 6 34 4 39 
4 2 6 2 8 
17 5 22 1 23 
24 9 33 4 2 39 
14 3 17 1 18 
15 5 20 2 22 
4 2 6 1 1 8 
9 2 11 10 11 33 
28 5 33 6 1 48 
9 1 10 2 1 2 16 
Total 
-__ 
N-terminal 
amino acid 
581 502 311 120 497 68 41 9 620 
(SeOb) Thr Thr Se1 Ser 
Hexose (%) 4.51 4.91 4.61 6.03 3.73 
Galactosamine (%) 1.53 1.43 0 5.15 1.55 
Glucosamine (%I 2.12 2.91 4.18 0 0 
Sialic acid (%) 4.35 5.45 3.82 10.09 2.09 
Total (%) 12.57 14.82 12.61 21.27 7.37 
Molecular 76 000”) 66 oooC*d) 48 500d) 16 OOOd) 8 OOOd) 4 600d) 
weight 
a) From ref. 6. 
b) Small amounts of wine (0.2 mole/mole) can be detected as N-terminal amino acid because HMW kininogen contains small amounts of kininogen which 
suffered limited proteolysis as discussed previously [ 181. 
c, Determined by sedimentation equilibrium method. 
d) Calculated from amino acid composition and carbohydrate content. 
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Fig.2. An alignment of the peptide segments and gross structural feature of bovine HMW kininogen. The arrows indicated show 
the sites cleaved by plasma kallikrein. CHO represents a carbohydrate chain. *Unreactive N-terminal residue with Edman’s and 
Sanger’s reagents. BK means bradykinin. - 
Lchains, has to constitute the N- and C-terminal por- 
tions of whole HMW kininogen, because their end 
groups are identical to those of the mother molecule. 
Since Lchain contains only one half-cystine residue, 
H- and Lchains constituting kinin-free kininogen are 
thought to be linked by a single disulfide bridge. 
Moreover, a sum of the total amino acid residues of 
H- and Lchains coincides with that of kinin-free 
kininogen and also the sum of those of kinin-free 
kininogen, fragment 1, fragment 2 and bradykinin 
with those of whole HMW kininogen produced by 
plasma kallikrein had been Q.olated. 
Based on these results, it seems now possible t,o 
build up a linear peptide sequence of HMW kininogen 
molecule and its gross structural feature, as shown in 
Fig.2. Thus, there should be at least four peptide bond 
cleavages associated with the kallikreinic digestion of 
HMW kininogen, yielding the kinin-free kininogen, 
fragment 1 (glycopeptide), fragment 2 (histidine-rich 
peptide) and vasoactive peptide, bradykinin. The 
results also indicate that the C-terminal polypeptide 
portion comprising Lchain, fragment 1 and fragment 
2 links oligosaccharide chains containing galactosa- 
mine, whereas the N-terminal portion comprising H- 
chain links those containing glucosamine. Moreover, 
it should be noted that HMW kininogen locates an 
abnormally histidine-rich peptide region near to the 
position of the kinin moiety along the polypeptide 
chain. Although the biological activities of fragments 
1 and 2 are scarcely known, a preliminary experiment 
indicates that these retard the generation of plasma 
kallikrein activity induced by a glass contact activa- 
tion of Hageman factor (Factor XII) [20] . The amino 
acid sequence studies of fragment 1 and L-chain des- 
cribed above are now in progress. 
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